Lifelong singles face greater life satisfaction challenges

As Ab­b­Vie con­tin­ues to tout its next gen­er­a­tion of im­munol­o­gy drugs be­hind Hu­mi­ra, it’s buy­ing an ear­ly-stage start­up to boost its longer-term prospects in in­flam­ma­to­ry

Positive 3-year results from the phase III PHOTON study were presented at the recent American Academy of Ophthalmology (AAO) meeting, demonstrating that patients with diabetic